Latest Health News

NTAW Holdings has secured an extension of its financial covenant waiver with Commonwealth Bank of Australia until March 2026, while continuing to reduce its borrowing facility.

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.

Credit Corp Group has submitted a non-binding indicative proposal to acquire Humm Group, marking a potential consolidation in the consumer finance sector. The proposal remains conditional as due diligence information is yet to be provided.

GPT Group has announced an estimated 12.0 cents per security distribution for the second half of 2025, alongside key dates for investor events in 2026.

Bendigo and Adelaide Bank has announced a fully franked quarterly dividend of AUD 1.311 per security on its Capital Note BENPH, payable in March 2026. This distribution reflects a steady income stream aligned with the terms set out in the 2020 prospectus.

Region Group announces a 6.9 cent per stapled security distribution for H1 FY26 and confirms its AFFO guidance of 14.0 cents per security for the full year.

Central Iron Ore Limited has announced a rights offering to raise up to $2.89 million, aiming to support its South Darlot joint venture, advance drilling at British King Mine, and repay a loan to majority shareholder Gullewa Limited.

Wellnex Life reports encouraging early results from its turnaround strategy, posting a modest EBITDA profit and robust sales growth for its Pain Away brand.

CONNEQT Health’s Pulse arterial health monitor sales have outpaced expectations with over 200% growth in the December quarter, driven by efficient marketing and early subscription uptake.

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2412 per Capital Note 3 security, payable in March 2026. The distribution reflects a 4.9784% annualised rate based on the BBSW plus a margin.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.